Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ekaterina L Andrianova

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Neuroscience Letters|December 11, 2007
Antioxidant and neuroprotective properties of N-arachidonoyldopamineMikhail Yu Bobrov, Anatoly A Lizhin, Ekaterina L Andrianova, et al.
Nature Communications|November 2, 2022
Unsupervised learning of aging principles from longitudinal dataKonstantin Avchaciov, Marina P Antoch, Ekaterina L Andrianova, et al.
Aging|September 29, 2021
Development of infrastructure for a systemic multidisciplinary approach to study aging in retired sled dogsDaria I Fleyshman, Joseph J Wakshlag, Heather J Huson, et al.
Mutation Research. Genetic Toxicology and Environmental Mutagenesis|May 4, 2017
Genotoxicity of two new carbazole derivatives with antifungal activityAliy K Zhanataev, Natalya V Eremina, Zlata V Chayka, et al.
Oncotarget|April 29, 2020
Superior cancer preventive efficacy of low versus high dose of mTOR inhibitor in a mouse model of prostate cancerMarina P Antoch, Michelle Wrobel, Bryan Gillard, et al.
Communications Biology|April 13, 2021
A deimmunized and pharmacologically optimized Toll-like receptor 5 agonist for therapeutic applicationsVadim Mett, Oleg V Kurnasov, Ivan A Bespalov, et al.
Leukemia|January 4, 2020
OT-82, a novel anticancer drug candidate that targets the strong dependence of hematological malignancies on NAD biosynthesisLioubov Korotchkina, Denis Kazyulkin, Pavel G Komarov, et al.
Cancer Research Communications|October 23, 2023
Cancer Relevance of Circulating Antibodies Against LINE-1 Antigens in HumansAlexandra V Vylegzhanina, Ivan A Bespalov, Ksenia A Novototskaya-Vlasova, et al.
Biorxiv : the Preprint Server for Biology|January 7, 2026
The Nicotinamide Salvage Pathway is a Metabolic Vulnerability of High-Risk MDS Stem CellsSweta B Patel, Daniel Moskop, Steven Moriera, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Neuroscience Letters|December 11, 2007
Antioxidant and neuroprotective properties of N-arachidonoyldopamineMikhail Yu Bobrov, Anatoly A Lizhin, Ekaterina L Andrianova, et al.
Nature Communications|November 2, 2022
Unsupervised learning of aging principles from longitudinal dataKonstantin Avchaciov, Marina P Antoch, Ekaterina L Andrianova, et al.
Aging|September 29, 2021
Development of infrastructure for a systemic multidisciplinary approach to study aging in retired sled dogsDaria I Fleyshman, Joseph J Wakshlag, Heather J Huson, et al.
Mutation Research. Genetic Toxicology and Environmental Mutagenesis|May 4, 2017
Genotoxicity of two new carbazole derivatives with antifungal activityAliy K Zhanataev, Natalya V Eremina, Zlata V Chayka, et al.
Oncotarget|April 29, 2020
Superior cancer preventive efficacy of low versus high dose of mTOR inhibitor in a mouse model of prostate cancerMarina P Antoch, Michelle Wrobel, Bryan Gillard, et al.
Communications Biology|April 13, 2021
A deimmunized and pharmacologically optimized Toll-like receptor 5 agonist for therapeutic applicationsVadim Mett, Oleg V Kurnasov, Ivan A Bespalov, et al.
Leukemia|January 4, 2020
OT-82, a novel anticancer drug candidate that targets the strong dependence of hematological malignancies on NAD biosynthesisLioubov Korotchkina, Denis Kazyulkin, Pavel G Komarov, et al.
Cancer Research Communications|October 23, 2023
Cancer Relevance of Circulating Antibodies Against LINE-1 Antigens in HumansAlexandra V Vylegzhanina, Ivan A Bespalov, Ksenia A Novototskaya-Vlasova, et al.
Biorxiv : the Preprint Server for Biology|January 7, 2026
The Nicotinamide Salvage Pathway is a Metabolic Vulnerability of High-Risk MDS Stem CellsSweta B Patel, Daniel Moskop, Steven Moriera, et al.
Pageof 1